Literature DB >> 2187005

Proliferative vitreoretinopathy--is it anything more than wound healing at the wrong place?

M Weller1, P Wiedemann, K Heimann.   

Abstract

Proliferative vitreoretinopathy (PVR) is a reactive process of the ocular tissue after perforating trauma, retinal detachment, and surgical manipulations. Although several studies, most of them experimental, have focused on the detection of specific etiologic factors in the development of PVR, there is compelling evidence that PVR is nothing more than a physiologic tissue repair process with undesirable consequences for the retina. Important features of PVR involving the role of platelets, mononuclear phagocytes, and fibroblasts parallel the chain of events observed in tissue repair elsewhere in the body. Numerous experimental models for PVR, originally designed to find specific stimuli for the generation of intraocular traction membrane formation, have shown that the process of PVR is the common pathway of the eye's reaction to vitreoretinal trauma of any kind. Accordingly, vitreoretinal surgeons could learn a lot from the work of other disciplines, e.g. surgery and dermatology, on wound healing, and the factors known to modify wound healing elsewhere in the body should be taken into consideration. The well-established impairment of tissue repair processes caused by medical treatment with corticosteroids and cytotoxic agents suggests a combined medical approach to PVR as an adjunct to surgical treatment, using refined methods of application and dosage. Steroids and cytotoxic drugs will influence the course of PVR by suppressing macrophage recruitment and the initial inflammatory reaction as well as the proliferative phase of wound healing with traction retinal detachment, respectively.

Entities:  

Mesh:

Year:  1990        PMID: 2187005     DOI: 10.1007/bf00154210

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  119 in total

Review 1.  Factors involved in the control of fibroblast proliferation by glucocorticoids: a review.

Authors:  S Durant; D Duval; F Homo-Delarche
Journal:  Endocr Rev       Date:  1986-08       Impact factor: 19.871

2.  Intravitreous fibronectin and platelet-derived growth factor. New model for traction retinal detachment.

Authors:  J H Yeo; J Sadeghi; P A Campochiaro; W R Green; B M Glaser
Journal:  Arch Ophthalmol       Date:  1986-03

3.  The pathophysiology of proliferative vitreoretinopathy.

Authors:  P Wiedemann; M Weller
Journal:  Acta Ophthalmol Suppl       Date:  1988

4.  The effects of injections of cultured fibroblasts into the rabbit vitreous.

Authors:  C A Hitchins; I Grierson; P S Hiscott
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1985       Impact factor: 3.117

5.  A prospective, randomized, clinical trial of heparin therapy for postoperative intraocular fibrin.

Authors:  R N Johnson; G Blankenship
Journal:  Ophthalmology       Date:  1988-03       Impact factor: 12.079

6.  Serum contains chemoattractants for human retinal pigment epithelial cells.

Authors:  P A Campochiaro; J A Jerdan; B M Glaser
Journal:  Arch Ophthalmol       Date:  1984-12

7.  Intraocular injection of silicone oil for experimental proliferative vitreoretinopathy.

Authors:  D M Fastenberg; K R Diddie; J M Delmage; K Dorey
Journal:  Am J Ophthalmol       Date:  1983-05       Impact factor: 5.258

8.  Effect of adriamycin on experimental proliferative vitreoretinopathy in the rabbit.

Authors:  M A Sunalp; P Wiedemann; N Sorgente; S J Ryan
Journal:  Exp Eye Res       Date:  1985-07       Impact factor: 3.467

9.  Vitrectomy in penetrating eye injury. Results of a controlled trial of vitrectomy in an experimental posterior penetrating eye injury in the rhesus monkey.

Authors:  P E Cleary; S J Ryan
Journal:  Arch Ophthalmol       Date:  1981-02

10.  Simulation of massive periretinal proliferation by autotransplantation of retinal pigment epithelial cells in rabbits.

Authors:  N D Radtke; Y Tano; D Chandler; R Machemer
Journal:  Am J Ophthalmol       Date:  1981-01       Impact factor: 5.258

View more
  28 in total

1.  Inhibitory effect of certain neuropeptides on the proliferation of human retinal pigment epithelial cells.

Authors:  J Troger; S Sellemond; G Kieselbach; M Kralinger; E Schmid; B Teuchner; Q A Nguyen; E Schretter-Irschick; W Göttinger
Journal:  Br J Ophthalmol       Date:  2003-11       Impact factor: 4.638

2.  Proliferative retinal diseases: myofibroblasts cause chronic vitreoretinal traction.

Authors:  R Walshe; P Esser; P Wiedemann; K Heimann
Journal:  Br J Ophthalmol       Date:  1992-09       Impact factor: 4.638

Review 3.  Strategies to influence PVR development.

Authors:  Bernd Kirchhof
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-08-10       Impact factor: 3.117

Review 4.  Involvement of Müller glial cells in epiretinal membrane formation.

Authors:  Andreas Bringmann; Peter Wiedemann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-05-05       Impact factor: 3.117

5.  Upregulated CD200 in pre-retinal proliferative fibrovascular membranes of proliferative diabetic retinopathy patients and its correlation with vascular endothelial growth factor.

Authors:  Yaguang Hu; Anming Xie; Qiaochu Cheng
Journal:  Inflamm Res       Date:  2019-10-14       Impact factor: 4.575

6.  Use of systemic steroid after successful macular surgery in eyes with epiretinal membrane: a randomized, controlled clinical study.

Authors:  M Ritter; S Sacu; G Matt; R Dunavölgyi; W Bühl; C Prünte; U Schmidt-Erfurth
Journal:  Eye (Lond)       Date:  2011-09-02       Impact factor: 3.775

7.  Retinal pigment epithelial cells: autocrine and paracrine stimulation of extracellular matrix contraction.

Authors:  S Grisanti; P Esser; U Schraermeyer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-09       Impact factor: 3.117

8.  Plasminogen in proliferative vitreoretinal disorders.

Authors:  P Esser; K Heimann; K U Bartz-Schmidt; P Walter; R Krott; M Weller
Journal:  Br J Ophthalmol       Date:  1997-07       Impact factor: 4.638

9.  Phosphorylation of extracellular signal-regulated kinase and p27(KIP1) after retinal detachment.

Authors:  Satoru Kase; Kazuhiko Yoshida; Takayuki Harada; Chikako Harada; Kazuhiko Namekata; Yukari Suzuki; Kazuhiro Ohgami; Kenji Shiratori; Keiichi I Nakayama; Shigeaki Ohno
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-08-02       Impact factor: 3.117

10.  Origin of fibronectin in epiretinal membranes of proliferative vitreoretinopathy and proliferative diabetic retinopathy.

Authors:  S Grisanti; K Heimann; P Wiedemann
Journal:  Br J Ophthalmol       Date:  1993-04       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.